Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0XVNKT
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
37788373 ADC2
|
|||||
| Synonyms |
ADC2
Click to Show/Hide
|
|||||
| Organization |
AbbVie Inc.; AbbVie Bioresearch Center.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
2.2
|
|||||
| Structure |
|
|||||
| Antibody Name |
Mouse CD19 antibody
|
Antibody Info | ||||
| Antigen Name |
B-lymphocyte antigen CD19 (CD19)
|
Antigen Info | ||||
| Payload Name |
(R)-Budesonide
|
Payload Info | ||||
| Therapeutic Target |
Glucocorticoid receptor (GR)
|
Target Info | ||||
| Linker Name |
MC-Val-Ala-RG-1
|
Linker Info | ||||
| Conjugate Type |
Site-specific antibody conjugation using modified bisected N-Glycans.
|
|||||